Both in Biotechnology
Acumen Pharmaceuticals vs BioCardia
Over the past year ABOS returned −89.2% and BCDA returned −36.0%; their daily moves had a correlation of 0.14.
ABOS −89.2% BCDA −36.0%Growth of $1, one year, split-adjusted
| Metric | ABOS | BCDA |
|---|---|---|
| Price | $0.2102 | $0.8510 |
| Market cap | $15.2M | $12.9M |
| Today | −2.82% | −6.80% |
| 1 month | −90.0% | −21.9% |
| 6 months | −91.5% | −21.9% |
| Year to date | −90.0% | −31.9% |
| 1 year | −89.2% | −36.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $52.3M | $4.1M |
| Dividend yield | — | — |
| Volatility (60d) | 492.8% | 69.4% |
| Short % of float | 7.6% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).